Handgretinger R - Search Results

1

Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target.

Böcker M, Chatziioannou E, Niessner H, Hirn C, Busch C, Ikenberg K, Kalbacher H, Handgretinger R, Sinnberg T. Böcker M, et al. Among authors: handgretinger r. Int J Mol Sci. 2024 Nov 4;25(21):11853. doi: 10.3390/ijms252111853. Int J Mol Sci. 2024. PMID: 39519404 Free PMC article.

2

In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival.

Menzel M, Meckbach D, Weide B, Toussaint NC, Schilbach K, Noor S, Eigentler T, Ikenberg K, Busch C, Quintanilla-Martinez L, Kohlhofer U, Göke A, Göke F, Handgretinger R, Ottmann C, Bastian BC, Garbe C, Röcken M, Perner S, Kohlbacher O, Bauer J. Menzel M, et al. Among authors: handgretinger r. Pigment Cell Melanoma Res. 2014 Jul;27(4):671-3. doi: 10.1111/pcmr.12249. Epub 2014 May 6. Pigment Cell Melanoma Res. 2014. PMID: 24703331 No abstract available.

3

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL.

Ureña-Bailén G, Dobrowolski JM, Hou Y, Dirlam A, Roig-Merino A, Schleicher S, Atar D, Seitz C, Feucht J, Antony JS, Mohammadian Gol T, Handgretinger R, Mezger M. Ureña-Bailén G, et al. Among authors: handgretinger r. Int J Mol Sci. 2022 Oct 24;23(21):12828. doi: 10.3390/ijms232112828. Int J Mol Sci. 2022. PMID: 36361619 Free PMC article.

4

T-helper-1-cell cytokines drive cancer into senescence.

Braumüller H, Wieder T, Brenner E, Aßmann S, Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C, Ranta F, Ullrich S, Mocikat R, Braungart K, Mehra T, Fehrenbacher B, Berdel J, Niessner H, Meier F, van den Broek M, Häring HU, Handgretinger R, Quintanilla-Martinez L, Fend F, Pesic M, Bauer J, Zender L, Schaller M, Schulze-Osthoff K, Röcken M. Braumüller H, et al. Among authors: handgretinger r. Nature. 2013 Feb 21;494(7437):361-5. doi: 10.1038/nature11824. Epub 2013 Feb 3. Nature. 2013. PMID: 23376950 Free article.

5

In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.

Grote S, Ureña-Bailén G, Chan KC, Baden C, Mezger M, Handgretinger R, Schleicher S. Grote S, et al. Among authors: handgretinger r. Cells. 2021 Apr 26;10(5):1020. doi: 10.3390/cells10051020. Cells. 2021. PMID: 33925968 Free PMC article.

6

Targeting hedgehog signalling by arsenic trioxide reduces cell growth and induces apoptosis in rhabdomyosarcoma.

Boehme KA, Zaborski JJ, Riester R, Schweiss SK, Hopp U, Traub F, Kluba T, Handgretinger R, Schleicher SB. Boehme KA, et al. Among authors: handgretinger r. Int J Oncol. 2016 Feb;48(2):801-12. doi: 10.3892/ijo.2015.3293. Epub 2015 Dec 15. Int J Oncol. 2016. PMID: 26676886

7

Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.

Kerl K, Moreno N, Holsten T, Ahlfeld J, Mertins J, Hotfilder M, Kool M, Bartelheim K, Schleicher S, Handgretinger R, Schüller U, Meisterernst M, Frühwald MC. Kerl K, et al. Among authors: handgretinger r. Int J Cancer. 2014 Aug 15;135(4):989-95. doi: 10.1002/ijc.28719. Epub 2014 Jan 25. Int J Cancer. 2014. PMID: 24420698

8

Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.

Boehme KA, Nitsch J, Riester R, Handgretinger R, Schleicher SB, Kluba T, Traub F. Boehme KA, et al. Among authors: handgretinger r. Int J Oncol. 2016 Nov;49(5):2135-2146. doi: 10.3892/ijo.2016.3700. Epub 2016 Sep 21. Int J Oncol. 2016. PMID: 27665785

9

Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia.

Riedt T, Ebinger M, Salih HR, Tomiuk J, Handgretinger R, Kanz L, Grünebach F, Lengerke C. Riedt T, et al. Among authors: handgretinger r. Blood. 2009 Apr 23;113(17):4049-51. doi: 10.1182/blood-2008-12-196634. Epub 2009 Feb 13. Blood. 2009. PMID: 19218548 Free article.

10

Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.

Woiterski J, Ebinger M, Witte KE, Goecke B, Heininger V, Philippek M, Bonin M, Schrauder A, Röttgers S, Herr W, Lang P, Handgretinger R, Hartwig UF, André MC. Woiterski J, et al. Among authors: handgretinger r. Int J Cancer. 2013 Oct 1;133(7):1547-56. doi: 10.1002/ijc.28170. Epub 2013 Apr 17. Int J Cancer. 2013. PMID: 23526331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters